|
PET and Nuclear Medicine
|
Nuclear Medicine uses unsealed sources of ionised radiation for the
diagnosis and treatment of numerous diseases. At present the Division can carry out all the main
scintigraphic tests used in oncology, cardiology, orthopaedics, endocrinology, neurology,
nephro-urology, gastroenterology and pneumology.
The main activity is focussed on molecular imaging with PET (Positron
Emission Tomography) radiopharmaceuticals, for clinical practice and research. The availability of
a radiopharmaceutical laboratory and a medical cyclotron, allows to produce specific
radiopharmaceuticals for oncologic diseases. Patients can have state-of-the-art imaging through a
PET-CT and a PET scanner installed in the Division.
Therapy with unsealed radioactive sources is performed in outpatient
affected by hyperthyroidism using radioiodine.
Special protected rooms enable to administrate to inpatient high doses
of radiopharmaceuticals, for the treatment of thyroid cancer, tumors expressing somatosttain
receptors, and for bone pain therapy. |
|
|
Chief:
Humanitas Cancer Center
